Related Experiment Video

Updated: Jan 16, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.5K

Revisiting a "new" yet "old" approach: Reticulocyte hemoglobin and related hematological indices for iron deficiency

Jesse Qiao1, Gagan Mathur1

  • 1Department of Pathology and Laboratory Medicine, University of California, Irvine, United States.

Transfusion
|October 2, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
anemiairon deficiencypatient blood managementreticulocyte hemoglobinscreening

More Related Videos

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K

Related Experiment Videos

Last Updated: Jan 16, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.5K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

5.7K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

4.7K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
4.7K

Articles linked to this work by shared authors, journal, and citation graph.

ABO and RhD blood group antigen frequencies in patients and blood donors: Implications for the U.S. blood supply.

PloS one·2026

Exploring low haemoglobin density as a no-added-cost screening marker to assess iron deficiency.

Vox sanguinis·2025

Developing a Protocol for Therapeutic Plasma Exchange in Tandem With Continuous Renal Replacement Therapy (CRRT) and ExtraCorporeal Membrane Oxygenation (ECMO) in Pediatric Patients.

Journal of clinical apheresis·2025

Prolonged COVID-19 infection in a patient with B-cell acute lymphoblastic leukemia maintained on convalescent plasma until recovery with monoclonal antibodies.

Laboratory medicine·2025

Key Issues at the Forefront of Diagnosis and Testing for Antiphospholipid Syndrome.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2024

Evaluating utility of routine ferritin testing in blood donors: A hospital-based blood donor centre experience.

Transfusion medicine (Oxford, England)·2024

A distinctive RhD serologic phenotype expressed by p.Glu233Lys RHD alleles DV type 5 and DAU4 in microplate agglutination RhD typing.

Transfusion·2026

Assessing the financial resources required to establish convalescent plasma collection programmes across Europe in response to a pandemic.

Transfusion·2026

Budget impact of implementing universal Plasmodium NAT screening in the blood transfusion system in the US.

Transfusion·2026

Employee motivators and barriers of workplace-supported blood donation.

Transfusion·2026

Co-design with community partners in blood donor recruitment: A global assessment.

Transfusion·2026

Mapping obstetric biobanks: A scoping review highlighting gaps in the study of alloimmunized pregnancies.

Transfusion·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us